Transitional dynamics in oncology clinical trials: evaluating the impact of Clinical Trials Act on cooperative groups
CONCLUSION: the number of multicentre clinical trials in oncology gradually decreased after the Clinical Trials Act's enforcement, which underscores the need for comprehensive amendment of the Clinical Trials Act to streamline the operational process.PMID:38535873 | DOI:10.1093/jjco/hyae034
Source: Clinical Lung Cancer - Category: Cancer & Oncology Authors: Kenichi Nakamura Koji Takeda Akiko M Saito Miho Kato Shinya Sato Satoshi Nakagawa Yasuyuki Kawamoto Eiji Oki Isamu Okamoto Hiroaki Okamoto Hiroshi Katayama Junki Mizusawa Harumi Kaba Taro Shibata Haruhiko Fukuda Source Type: research
More News: Cancer | Cancer & Oncology | Clinical Trials | Japan Health | Lung Cancer | Medical Ethics | Transitional Cell Carcinoma